Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LYPLA1P2 (Lysophospholipase 1 pseudogene 2) is a non-functional DNA sequence on the human genome resembling the LYPLA1 gene, which encodes a depalmitoylating enzyme involved in lipid metabolism and signaling. Multiple LYPLA1 pseudogenes, including LYPLA1P2, are present on different human chromosomes; none are known to encode active protein products or to function as molecular targets in pharmacology[1][4]. If you meant the functional gene/protein “Lysophospholipase 1 (LYPLA1)” and not the pseudogene, please clarify—LYPLA1 is an enzyme (acyl-protein thioesterase 1, APT1) with established roles and possible disease relevance[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysophospholipase 1 pseudogene 2 (LYPLA1P2).